Govindasamy Muralidharan Karthik

Learn More
BACKGROUND Recognizing specific protein changes in response to drug administration in humans has the potential for the development of personalized medicine. Such changes can be identified by pharmacoproteomics approach based on proteomic technologies. It can also be helpful in matching a particular target-based therapy to a particular marker in a subgroup(More)
BACKGROUND The expression of oestrogen receptor (ER) α characterises a subset of breast cancers associated with good response to endocrine therapy. However, the clinical significance of the second ER, ERβ1, and its splice variant ERβcx is still unclear. METHODS We here report an assessment of ERα, ERβ1 and ERβcx by immunohistochemistry using quantitative(More)
  • 1